泌尿生殖道支原体培养及药敏结果分析

目的探讨泌尿生殖道支原体感染及耐药现状，为临床用药提供依据。方法对2007～2008年来笔者所在医院就诊的1733例疑似泌尿生殖道感染患者进行支原体培养，对阳性患者进行药敏试验。结果1733例疑似患者中支原体阳性911例（52．6％），其中Uu822（47．4％）、Uu＋Mh混合感染89（5．1％）；女性支原体发病率较男性高；药敏结果表明：耐药率较低的依次为交沙霉素（2．7％）、美满霉素（6．1％）、强力霉素（5．7％）。结论支原体是泌尿生殖道感染的主要病原体，临床应该重视支原体的培养与药敏试验，合理选择抗生素。目前我市支原体感染患者应首选交沙霉素进行治疗。

Mycoplasma culture from the urogenital tract and drug sensitivity analysis

Objective To investigate the urogenital tract mycoplasma infection and drug resistance status and to provide a basis for the clinical medication. Methods Form 2007 to 2008 year, the autor had hospital treatment in 1733 cases of suspected urinary tract infection in patients with mycoplasma culture, drug susceptibility testing of positive patients. Results 1733 cases of suspected patients, 911 eases of myeoplasma - positive （52.6%）, in which Uu822 was 47.4%, Uu ＋ Mh mixed infection was 5.1% ; women than men of high incidence of mycoplasma. Drug sensitivity test showed that ： resistance followed by low rates of josamycln （2.7%） , minocycllne （6.1%） , doxycycline （5.7%）. Conclusion Urogenital tract myeoplasma is a major pathogens, we should pay attention to the cultivation of mycoplasma and drug sensitivity test and choose a reasonable antibiotics. At our city, patients with myeoplasma infection should be preferentially treated with josamycin.